FindTrial
Sign In

Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1

Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00067158
Enrollment
585
Registered
2003-08-13
Start date
2003-04-30
Completion date
2004-07-31
Last updated
2017-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Use Disorder

Keywords

nicotine dependence

Brief summary

The purpose of this study is to look at how feasible it is to incorporate a state-of-the-art smoking cessation treatment program into community substance abuse treatment programs and its impact on substance abuse and cigarette smoking.

Interventions

DRUGnicotine transdermal system

Sponsors

New York University
Lead SponsorOTHER

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Patient is alcohol or drug dependent, in Outpatient Drug-Free or Opiate Substitute program and is interested in quitting smoking

Exclusion criteria

* Patient is psychotic * Use of smokeless tobacco * Use of other smoking cessasation product * Pregnancy * Patient has hyper-tension, heart problems, or skin condition

Design outcomes

Primary

MeasureTime frame
Drug use—
Smoking Cessation—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026